Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kristopher Kolibab"'
Autor:
Marcela Parra, Xia Liu, Steven C Derrick, Amy Yang, Jinhua Tian, Kristopher Kolibab, Sanjai Kumar, Sheldon L Morris
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e66115 (2013)
Although the effectiveness of BCG vaccination in preventing adult pulmonary tuberculosis (TB) has been highly variable, epidemiologic studies have suggested that BCG provides other general health benefits to vaccinees including reducing the impact of
Externí odkaz:
https://doaj.org/article/c2479cd7bc034c8782ab0b4dfc69ac5d
Autor:
Marcela Parra, Steven C Derrick, Amy Yang, Jinhua Tian, Kristopher Kolibab, Miranda Oakley, Liyanage P Perera, William R Jacobs, Sanjai Kumar, Sheldon L Morris
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e28164 (2011)
BackgroundGiven the considerable geographic overlap in the endemic regions for malaria and tuberculosis, it is probable that co-infections with Mycobacterium tuberculosis and Plasmodium species are prevalent. Thus, it is quite likely that both malari
Externí odkaz:
https://doaj.org/article/df3c96438f09451bb3997b3c63abd179
Publikováno v:
Vaccine. 33:126-132
While formulating Mycobacterium bovis BCG in lipid-based adjuvants has been shown to increase the vaccine's protective immunity, the biological mechanisms responsible for the enhanced potency of lipid encapsulated BCG are unknown. To assess whether m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2eac167217a4ee1e5ced94f135379db
https://doi.org/10.1016/j.vaccine.2014.11.004
https://doi.org/10.1016/j.vaccine.2014.11.004
Autor:
Sheldon L. Morris, Amy Li Yang, Steven C. Derrick, Marcela Parra, Kristopher Kolibab, Liyanage P. Perera
Publikováno v:
Vaccine. 28:317-322
New vaccines and novel immunization strategies are needed to improve the control of the global tuberculosis epidemic. To facilitate vaccine development, we have been creating in vitro mycobacterial intra-macrophage growth inhibition assays. Here we d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f49b9900b109db7c67a2d1d5c9411832
https://doi.org/10.1016/j.vaccine.2009.10.047
https://doi.org/10.1016/j.vaccine.2009.10.047
Autor:
Masafumi Yamamoto, Steven C. Derrick, Fumiki Momoi, Liyanage P. Perera, Sheldon L. Morris, Pin-Yu Perera, Thomas A. Waldmann, Kristopher Kolibab
Publikováno v:
Vaccine. 27:2121-2127
Tuberculosis caused by Mycobacterium tuberculosis is responsible for nearly two million deaths every year globally. A single licensed vaccine derived from Mycobacterium bovis, bacille Calmette-Guerin (BCG) administered perinatally as a prophylactic v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7fa730520ee44552a1ef39cf068d0f6
https://doi.org/10.1016/j.vaccine.2009.01.132
https://doi.org/10.1016/j.vaccine.2009.01.132
Autor:
Amy Li Yang, JaeHyun Lim, Veerabadran Dheenadhayalan, Barry N. Kreiswirth, Bo Young Jeon, Steven C. Derrick, Sheldon L. Morris, Kristopher Kolibab
Publikováno v:
Infection and Immunity. 76:5173-5180
Recent preclinical and epidemiologic studies have suggested that certainMycobacterium tuberculosisgenotypes (in particular, Beijing lineage strains) may be resistant toMycobacterium bovisBCG vaccine-induced antituberculosis protective immunity. To in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39dc9e1c976710f6b6bcf46f6b016bf5
https://doi.org/10.1128/iai.00019-08
https://doi.org/10.1128/iai.00019-08
Publikováno v:
Clinical and vaccine immunology : CVI. 21(10)
Despite the widespread use ofMycobacterium bovisBCG, the only licensed vaccine against tuberculosis (TB), TB remains a global epidemic. To assess whether more direct targeting of the lung mucosa by respiratory immunization would enhance the potency a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c04824d2351cdf1da51e06bdcb560e6
https://pubmed.ncbi.nlm.nih.gov/25143340
https://pubmed.ncbi.nlm.nih.gov/25143340
Clinical studies have suggested that the enumeration of mycobacteria by using automated liquid systems is a faster and simpler alternative to quantitative cultures. Here, we show that the time to detection ofM. tuberculosisgrowth as measured with the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28703f4b88d12fdac31f55a23112e1cb
https://europepmc.org/articles/PMC3957671/
https://europepmc.org/articles/PMC3957671/
Autor:
Amy Yang, Kristopher Kolibab, Idalia M. Yabe, Sheldon L. Morris, Sherry L. Kurtz, Steven C. Derrick, Brynn Hollingsworth
Publikováno v:
Vaccine. 31(41)
With tuberculosis continuing to be a major cause of global morbidity and mortality, a new vaccine is urgently needed. Tuberculosis subunit vaccines have been shown to induce robust immune responses in humans and are a potentially safer alternative to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71d53d6766af157a854f934a83429498
https://pubmed.ncbi.nlm.nih.gov/23906890
https://pubmed.ncbi.nlm.nih.gov/23906890
Autor:
Xia Liu, Jinhua Tian, Sanjai Kumar, Sheldon L. Morris, Amy Yang, Marcela Parra, Steven C. Derrick, Kristopher Kolibab
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e66115 (2013)
PLoS ONE
PLoS ONE
Although the effectiveness of BCG vaccination in preventing adult pulmonary tuberculosis (TB) has been highly variable, epidemiologic studies have suggested that BCG provides other general health benefits to vaccinees including reducing the impact of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04155d32720a05a1e9aca25203984582
http://europepmc.org/articles/PMC3701530?pdf=render
http://europepmc.org/articles/PMC3701530?pdf=render